ABSTRACT
Objectives:
The aim of this study was to evaluate
the association between progressive
sensorineural hearing loss and normal
tension glaucoma.
Materials and
methods: This prospective study
was conducted in South Shouna Hospital
(Ministry of Health- Jordan) during
the period between 2003 - 2005. 26
patients attending an ophthalmology
clinic and diagnosed to have normal
tension glaucoma were referred to
the ENT clinic. Ophthalmologic examination
included Snellen's visual acuity testing,
anterior segment examination via slit
lamp, and posterior segment examination
after mydriasis via indirect ophthalmoscope,
Goldmann's applanation tonometry to
measure intraocular pressure, and
visual field assessment via Goldmann's
perimeter. In the ENT clinic, audiograms,
stapedial thresholds and otoacoustic
emissions were obtained. Serological
testing of antiphospholipids antibodies
were done for all patients. The results
were compared with two control groups:
one had other types of glaucoma, and
the other was normal people.
Results:
18 normal tension glaucoma patients
(75%) had sensorineural hearing loss.
Elevated antiphospholipid antibody
concentrations were more frequent
in patients with normal tension glaucoma
and hearing loss compared with normal
tension glaucoma patients with normacusis.
There was no association between primary
open angle glaucoma, hearing loss
and antiphospholipid antibody. Pseudoexfoliation
was associated with hearing loss but
not with antiphospholipid antibodies.
Conclusions:
The association between hearing loss,
normal tension glaucoma and antiphospholipid
antibody indicates that they are part
of autoimmune systemic process.
Keywords:
Progressive sensorineural hearing
loss, normal tension glaucoma, antiphospholipid
antibodies, and autoimmune diseases.
|
In
recent years, the understanding of development
and progression of glaucomatous optic nerve
damage has changed. There is accumulating
evidence for a multifactorial pathogenesis
of glaucomatous optic neuropathy. Besides
an elevated intraocular pressure, there
is special emphasis on cardiovascular and
haematological risk factors and also on
genetic and immunological aspects 1-3.
Recently, Kremmer et al 4 found
elevated levels of a subgroup of antiphospholipid
antibodies in patients with normal tension
glaucoma (NTG) compared to patients with
primary open angle glaucoma (POAG) and age
matched healthy controls. These findings
may be interpreted as a sign for a generalised
disease.
Although the pathogenesis
of progressive sensorineural hearing loss
(PSHL) often remains unclear some research
activities have focused on the role of autoantibodies
against antigens in the inner ear. This
concept was introduced by Reinhardt 5
and is supported by the fact that hearing
loss is associated with different autoimmune
diseases such as Cogan syndrome, rheumatoid
arthritis, Sjögren syndrome, and Behçet's
disease 6-8.
Hisashi et al 9
were the first to demonstrate an association
between progressive sensorineural hearing
loss in patients with lupus erythematosus
and antiphospholipid antibodies. They proposed
that in patients with lupus erythematosus
these antibodies are causative for thrombosis
of the labyrinth leading to progressive
sensorineural hearing loss.
Phospholipids are constituents
of all membranes and are divided in many
subspecies such as phosphatidylserine (APSA).
It has been theorised that APSA can be generated
by any pathological conditions shifting
phosphatidylserine from the inner membrane
leaflets to the external membrane leaflets
of cells 10. This shift is the
beginning of the apoptotic mechanism and
leads to cell destruction and ischemia in
endothelial cells 11. This permits
a number of phospholipid binding proteins
to be presented to the immune system in
unique antigenic conformations, giving rise
to antibody production.
The aim of this study was to investigate
a possible coincidence between NTG, PSHL
and the association to APSA.
|
|
This
prospective study was conducted in South
Shouna Hospital during the period between
2003 - 2005. 26 patients attending ophthalmology
clinic and diagnosed as normal tension glaucoma
(typical optic disc and visual field damage
and intraocular pressure below 21 mmHg)
were referred to the ENT clinic. Ophthalmologic
examination included Snellen's visual acuity
testing, anterior segment examination via
slit lamp, and posterior segment examination
after mydriasis via indirect ophthalmoscope,
Goldmann's applanation tonometry to measure
intraocular pressure, and visual field assessment
via Goldmann's perimeter. In ENT clinic,
audiograms, stapedial thresholds and otoacoustic
emissions were obtained.
Hearing loss was compared
to previously established hearing thresholds
in patients with normal hearing and presbyacusis.
Presbyacusis was defined as hearing loss
of high frequencies in elderly people whereas
PSHL was age independent. Serological testing
of antiphospholipids antibodies were done
for all patients. APSA level of >15 U/ml
was considered elevated.
The mean age of patients with
NTG was 64.8 years; 15 females and 9 males
(Table 1). 18 normal tension glaucoma
patients (75%) had sensorineural hearing
loss: 10 (41.7%) were pathological and 8
(33.3%) had presbyacusis (Table
2). Elevated antiphospholipids antibodies
concentrations were more frequent in patients
with normal tension glaucoma and hearing
loss compared with normal tension glaucoma
patients with normacusis (Table
3) or other types of glaucoma. Among
the other types of glaucoma, primary open
angle glaucoma was seen in 10 patients and
pseudoexfoliation glaucoma in 8 patients.
In
the past few years it was shown that autoimmune
phenomena are associated with hearing loss.
Namedrop et al 12 found a correlation between
sudden hearing loss and systemic lupus erythematosus.
Moreover, progressive hearing loss may be
associated with increased autoantibody levels:
Tomato et al 7 were able to demonstrate
an increased concentration of IgG anticardiolipin
antibodies in 30% of patients with Sjögren's
syndrome and sensorineural hearing loss.
In principle, two different
entities of autoantibodies were found to
be associated with glaucoma: autoantibodies
against specific proteins of the retina
and the optic nerve 13-14 or against more
common antigens 15-16 such as extractable
nuclear antigens, small heat shock proteins
and serum antibodies against neuron specific
enolase.
Interestingly, Shokoohi
et al 17 reported on elevated antiphospholipid
antibodies in NTG and POAG patients. APSA
are a subgroup of antiphospholipid antibodies
which are one of the hallmarks of the antiphospholipid
syndrome. APSA may be important because
of their binding specificity to phosphatidylserine
molecules which become accessible during
apoptosis, which in turn may lead to local
thrombosis.
Interestingly, a higher
prevalence of antiphosphatidylserine antibodies
was seen in NTG patients with hearing loss
in comparison to NTG patients with normacusis.
This finding suggests a similar pathological
pathway as a sign for generalised disease.
The increase of the same antibody entity
in patients suffering from both, NTG and
PSHL may indicate an association with similar
systemic autoimmune processes.
Patients with presbyacusis
or PSHL showed a small difference compared
to patients with normacusis, suggesting
that some patients with presbyacusis also
have elevated antiphosphatidylserine antibodies.
This is not surprising because antiphospholipid
antibodies increase with age. The smaller
occurrence of hearing loss compared to normal
tension glaucoma might be explained by the
fact that the terminal vessel pathway in
the eye seems to be more vulnerable to blood
supply disturbances or patients are more
sensitive to the sense of vision than to
hearing. It has been shown that apoptosis
can be induced by antiphosphatidylserine
antibodies, which results in occlusion of
small vessels by thromboemboli and finally
leads to disturbance of the microcirculation
in the inner ear and eye.
Pseudoexfoliative glaucoma
was associated with PSHL but with almost
similar APSA level with normal people of
same age group. This may be explained by
the fact that Pseudoexfoliation is considered
as a systemic disease affecting many organs
in the body 18.
The association between hearing loss, normal
tension glaucoma and antiphospholipid antibody
indicates that they are part of autoimmune
systemic process. Based on these findings
all patients with NTG or significant hearing
loss and elevated levels of antibodies against
phosphatidylserine should have further ophthalmological
or otological work up
|
1. |
Durance
SM, Sweeney VP, Morgan RW, et al. Studies
of factors involved in the production
of low tension glaucoma. Arch Ophthalmology
1973; 89:457-65. |
2. |
Flammer
J, Orgul S, Costa VP, et al. The impact
of ocular blood flow in glaucoma. Prog
Retin Eye Res 2002; 21:359-93. |
3. |
Grunwald
JE, Piltz J, Hariprasad SM, et al. Optic
nerve blood flow in glaucoma: effect
of systemic hypertension. Am J Ophthalmology
1999; 127:516-22. |
4. |
Kremmer
S, Kreuzfelder E, Klein R, et al. Antiphosphatidylserine
antibodies are elevated in normal tension
glaucoma. Clin Exp Immunol 2001;125:211-15.
|
5. |
Reinhardt
E. Plötzliche Hörstörungen,
auf beiden Seiten gleichzeitig auftretend
oder nacheinander auftretend. Laryngo-Rhino-Otol
1958;37:1-5. |
6. |
Hughes
GB, Barna BP, Kinney SE, et al. Clinical
diagnosis of immune inner-ear disease.
Laryngoscope 1988;98:251-3. |
7. |
Tomato
B, Casoli P, Parmeggiani A. Hearing
loss in the Sjogren syndrome. Ann Intern
Med 1997;126:450-3. |
8. |
Eichhorn
A, Kirch W. Sicca-Symptomatik und Hörverlust
beim Behcet's Syndrom. Dtsch Med Wochenschr
1998;123:663-6. |
9. |
Hisashi
K, Komune S, Taira T, et al. Anticardiolipin
antibody-induced sudden profound sensorineural
hearing loss. Am J Otolaryngol 1993;14:275-7. |
|
|
10. |
Bevers
EM, Confurius P, Dekkers DWC, et al.
Regulatory mechanisms of transmembrane
phospholipid distributions and pathophysiological
implications of transbilayer lipid scrambling.
Lupus 1998;7 (Suppl 2) :S126-31. |
11. |
Lockwood
CJ, Rand JH. The immunobiology and obstetrical
consequences of antiphospholipid antibodies.
Obstet Gynecol Surv 1994;49:432-41. |
12. |
Namedrop
M, Spiera H. Sudden sensorineural hearing
loss in patients with systemic lupus
erythematosus or lupus-like syndromes
and antiphospholipid antibodies. J Rheumatol
1998;25:589-92. |
13. |
Ikeda
Y, Ohguro H, Maruyama I. Two cases of
primary open angle glaucoma with serum
autoantibody against retinal ganglion
cells. Jpn J Ophthalmology 2000;44:648-52. |
14. |
Yang
J, Tezel G, Patil RV, et al. Serum autoantibody
against glutathione S-transferase in
patients with glaucoma. Invest Ophthalmology
Vis Sci 2001;42:1273-6. |
15. |
Ikeda
Y, Maruyama I, Nakazawa M, et al. Clinical
significance of serum antibody against
neuron-specific enolase in glaucoma
patients. Jpn J Ophthalmology 2002;46:13-17. |
16. |
Maruyama
I, Maeda T, Okisaka S, et al. Autoantibody
against neuron-specific enolase found
in glaucoma patients causes retinal
dysfunction in vivo. Jpn J Ophthalmology
2002;46:1-12. |
17. |
Shokoohi
KK, Shin DH, Elliott D, et al. Antiphospholipid
antibodies in patients with normal tension
glaucoma. Invest Ophthalmology Vis Sci
1999; 40 (Suppl) :342. |
18. |
Sha'ban
R, Asfour W, Kaabneh K. Ocularpseudoexfoliation
associated with hearing loss. The 2nd
International conference of Royal Jordanian
Medical Services 2003; 300. |
|